HLA-A and neuroblastoma: We then performed immunopeptidomics on eight high-risk diagnostic neuroblastoma primary tumours, focusing on HLA-A*02:01 and HLA-A*24:02 allotypes (Extended Data Table 1a, Supplementary Table 1).